Profile
Derek Croote is the founder and has held the title of Chief Technology Officer at IgGenix, Inc. since 2019.
He received an undergraduate degree from Brown University and a doctorate from Stanford University.
Derek Croote active positions
| Companies | Position | Start |
|---|---|---|
IgGenix, Inc.
 IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Founder | 2018-12-31 |
Training of Derek Croote
| Brown University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
IgGenix, Inc.
IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Derek Croote
